Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950162-07-000001
Filing Date
2007-01-03
Accepted
2007-01-03 09:40:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 REGENERX BIO/SIGMA TAU 13D/A NO.8 sigmatau13dano8_122106.htm SC 13D/A 246403
  Complete submission text file 0000950162-07-000001.txt   248298
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 07500942
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address
SIGMA TAU FINANZIARIA SPA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: SC 13D/A